Back/High Q Technologies Launches EPR Measurement Service to Support Structural Biology Research
pharma·September 17, 2025·epr

High Q Technologies Launches EPR Measurement Service to Support Structural Biology Research

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • High Q Technologies launches an EPR measurement service for structural biology, enhancing research capabilities for academia and industry.
  • The service addresses funding challenges by providing access to EPR technology without requiring labs to purchase equipment.
  • High Q's FATHOM EPR systems complement advanced research methods, supporting scientists studying complex biological systems.

High Q Technologies Launches Innovative EPR Measurement Service for Structural Biology

High Q Technologies, a leader in quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers, unveils its High Q Sample Measurement Service, designed specifically for the structural biology community. This new service allows researchers, both in academia and the pharmaceutical industry, to send samples for analysis utilizing High Q’s advanced FATHOM EPR systems. The initiative addresses a critical void in the structural biology toolkit, particularly in challenging research areas such as intrinsically disordered proteins (IDPs), PROTACs, and membrane proteins. With the growing complexity of biological research, the introduction of this service represents a significant step forward in providing researchers with the precise data they need to advance their studies.

Don Carkner, Vice President of Operations at High Q Technologies, emphasizes the increasing necessity for EPR data in light of dwindling National Institutes of Health (NIH) funding, which has seen a reduction of over $3.5 billion in 2025. This decline complicates labs' ability to acquire resources for large capital investments, making High Q's service a timely solution. By enabling researchers to access sophisticated measurement capabilities without the burden of purchasing equipment, High Q Technologies effectively supports ongoing scientific discovery during a period of financial constraint.

Rudra Maharajh, Director of Product Management, highlights that the High Q Sample Measurement Service is a lifeline for laboratories that may lack both EPR technology and the funds to invest in their own instruments. Each sample submitted will receive a comprehensive report, detailing distance distribution and characterization, which is suitable for publication. Set to commence in the fourth quarter of 2025, this service not only enhances the research capabilities of institutions but also complements existing technologies like AlphaFold and Cryo-EM, reaffirming High Q Technologies' dedication to advancing structural biology research.

In addition to this new service, High Q Technologies continues to market its FATHOM EPR systems, thereby expanding its footprint in the evolving landscape of scientific research. The company’s commitment to providing innovative solutions is evident in its response to the growing demands of researchers grappling with complex biological systems and limited resources. More information about the High Q Sample Measurement Service and the FATHOM EPR systems can be accessed on their website.

This initiative underscores High Q Technologies' role in shaping the future of structural biology, ensuring that vital EPR data remains accessible to researchers striving to unlock the mysteries of life at the molecular level.